Patents by Inventor Larry Allen Cabell

Larry Allen Cabell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8722706
    Abstract: The present invention relates to two phase systems of a bioactive ingredient in particle form that has limited or no solubility in a liquid medium, which provides stability to the bioactive ingredient that is similar to the bioactive ingredient when in the solid state. The bioactive ingredient may be capable of therapeutically treating for the presence of a cholinesterase inhibitor. The bio active ingredient comprises 1,1?-methlyenebis[4-[(hydroxyimino)methyl]-pyridinium]dimethanesulfonate.
    Type: Grant
    Filed: August 15, 2008
    Date of Patent: May 13, 2014
    Assignee: Southwest Research Institute
    Inventors: Hong Dixon, Joseph A McDonough, Larry Allen Cabell, Patricia Underwood
  • Patent number: 8404850
    Abstract: Bis-quaternary pyridinium-aldoxime salts are disclosed, and their associated polymorphic character, along with their methods of preparation. Such polymorphic salts may then be used for treatment of exposure to cholinesterase inhibitors, such as a phosphorous containing cholinesterase inhibitor type compound.
    Type: Grant
    Filed: March 13, 2008
    Date of Patent: March 26, 2013
    Assignee: Southwest Research Institute
    Inventors: Larry Allen Cabell, Joseph A McDonough
  • Patent number: 8309134
    Abstract: The present disclosure relates to non-aggregating nanoparticles and their associated methods of preparation. The nanoparticles may have a surface and a size range of 1 nm to 999 nm, along with a zeta potential of ?50 to 50 millivolts. A polycation and/or polyanion may be disposed on the nanoparticle surface. In addition, an active ingredient may be encapsulated within the nanoparticles or associated with the polycation or polyanion on the nanoparticle surface.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: November 13, 2012
    Assignee: Southwest Research Institute
    Inventors: Joseph A McDonough, Hong Dixon, Maria Lucy Kimmel, Larry Allen Cabell, Stephen T. Wellinghoff
  • Publication number: 20100086601
    Abstract: The present disclosure relates to non-aggregating nanoparticles and their associated methods of preparation. The nanoparticles may have a surface and a size range of 1 nm to 999 nm, along with a zeta potential of ?50 to 50 millivolts. A polycation and/or polyanion may be disposed on the nanoparticle surface. In addition, an active ingredient may be encapsulated within the nanoparticles or associated with the polycation or polyanion on the nanoparticle surface.
    Type: Application
    Filed: October 3, 2008
    Publication date: April 8, 2010
    Applicant: SOUTHWEST RESEARCH INSTITUTE
    Inventors: Joseph A. McDONOUGH, Hong DIXON, Maria Lucy KIMMEL, Larry Allen CABELL, Stephen T. WELLINGHOFF
  • Publication number: 20100040692
    Abstract: The present invention relates to two-phase systems of a bioactive ingredient in particle form that has limited or no solubility in a liquid medium, which provides stability to the active ingredient that is similar to the active ingredient when in the solid state. The active ingredient may be capable of therapeutically treating for the presence of a cholinesterase inhibitor.
    Type: Application
    Filed: August 15, 2008
    Publication date: February 18, 2010
    Applicant: SOUTHWEST RESEARCH INSTITUTE
    Inventors: Hong Dixon, Joseph A. McDonough, Larry Allen Cabell, Patricia Underwood
  • Publication number: 20090281144
    Abstract: Bis-quaternary pyridinium-aldoxime salts are disclosed, and their associated polymorphic character, along with their methods of preparation. Such polymorphic salts may then be used for treatment of exposure to cholinesterase inhibitors, such as a phosphorous containing cholinesterase inhibitor type compound.
    Type: Application
    Filed: March 13, 2008
    Publication date: November 12, 2009
    Applicant: SOUTHWEST RESEARCH INSTITUTE
    Inventors: Larry Allen CABELL, Joseph A. McDONOUGH
  • Patent number: 6534316
    Abstract: Methods are disclosed for the simple, rapid, and selective colorimetric detection of carbohydrates, including fructose, glucose, sialic acid, and oligosaccharides. There is no need for any prior hydrolysis or other chemical modification or of the analytes. Resorcinarenes, xanthene dyes, and related compounds, formally produced by the reaction of 2 equivalents of resorcinol and a suitable electrophilic condensation partner, are used as chromophores or fluorophores for the detection of sugars and other carbohydrates.
    Type: Grant
    Filed: February 5, 2001
    Date of Patent: March 18, 2003
    Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Robert M. Strongin, Larry Allen Cabell, Nadia St. Luce, Patrick T. Lewis, Ming He, Jorge O. Escobedo Cordova, Claude Joseph Davis
  • Publication number: 20020142475
    Abstract: Methods are disclosed for the simple, rapid, and selective colorimetric detection of carbohydrates, including fructose, glucose, sialic acid, and oligosaccharides. There is no need for any prior hydrolysis or other chemical modification or of the analytes. Resorcinarenes, xanthene dyes, and related compounds, formally produced by the reaction of 2 equivalents of resorcinol and a suitable electrophilic condensation partner, are used as chromophores or fluorophores for the detection of sugars and other carbohydrates.
    Type: Application
    Filed: February 5, 2001
    Publication date: October 3, 2002
    Inventors: Robert M. Strongin, Larry Allen Cabell, Nadia St. Luce, Patrick T. Lewis, Ming He, Jorge O. Escobedo Cordova, Claude Joseph Davis